In a mouse model of Duchenne muscular dystrophy, the upregulation of ACE2 expression or the administration of Ang-(1–7) were observed to reduce the skeletal muscle fibrosis and to ameliorate skeletal muscle structure and function [10, 21, 22]. Here, ACE2 is linked to Duchenne muscular dystrophy.